EVNIN LUKE sold 20.1% of their position (191.76K shares) of WEREWOLF THERAPEUTICS, INC. on the open market
Open‑market sale worth $86.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/26/2026ACC: 0001134657-26-000014
Director10% Owner
Since Apr 2021
-191.76K
Net shares
Net seller
$86.6K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
191.76K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−36.39K
Price / share
$0.42
Trade value
$15.28K
% of position
3.8%
5/21/2026
955.45K→919.06K
Common Stock
Indirect
Shares
−87.42K
Price / share
$0.45
Trade value
$39.34K
% of position
9.5%
5/22/2026
919.06K→831.63K
Common Stock
Indirect
Shares
−67.95K
Price / share
$0.47
Trade value
$31.94K
% of position
8.2%
5/26/2026
831.63K→763.68K
Total
Net shares
−191.76K
Net value
-$86.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/21/2026 | S · Sale | −36.39K | $0.42 | $15.28K | 3.8% | 955.45K | 919.06K |
| Common Stock Indirect | 5/22/2026 | S · Sale | −87.42K | $0.45 | $39.34K | 9.5% | 919.06K | 831.63K |
| Common Stock Indirect | 5/26/2026 | S · Sale | −67.95K | $0.47 | $31.94K | 8.2% | 831.63K | 763.68K |
| Total | −191.76K | -$86.56K | ||||||
Derivative Transactions0
No derivative transactions reported